Sunmi Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sunmi Lee has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Sun Ha Jee
Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea
10 shared publications - Keum Ji Jung
Institute for Health Promotion, Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University , Seoul
8 shared publications - Heejin Kimm
Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea
5 shared publications - Yeun Soo Yang
Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea
5 shared publications - So Young Kim
Health Insurance Research Institute, National Health Insurance Service, Wonju, Korea, Wonju, Korea
3 shared publications - Eunsil Cheon
Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, Korea
2 shared publications
Latest Publications
- 1 October 2026
- Published by Korean Society for Health Education and Promotion in Korean Journal of Health Education and Promotion
- Vol. 43 (4) , 21-32
Development of evaluation indicators for general health screening institutions to enhance follow-up care
- 1 October 2026
- Published by Korean Society for Health Education and Promotion in Korean Journal of Health Education and Promotion
- Vol. 43 (4) , 21-32
Development of evaluation indicators for general health screening institutions to enhance follow-up care
- Open Access
- 29 July 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025040
Cohort profile update: the Korean Cancer Prevention Study-II (KCPS-II) biobank
Chronic diseases such as cancer and cardiovascular disease have a substantial impact on mortality and global disease burden. The Korean Cancer Prevention Study-II (KCPS-II) biobank was established to investigate these chronic diseases, with a particular focus on metabolic risk factors. Recently, genetic information reflecting diverse ancestries has been incorporated to support a precision medicine approach. These data can be leveraged to identify variation in causal effects among different ancestral groups, thereby informing the development of more effective, ancestry-specific treatments. From 2004 to 2013, baseline data were collected from 156,701 individuals aged 20-85 years, recruited from 18 health promotion centers across Korea. Outcome data are routinely obtained from Statistics Korea (mortality data), the National Cancer Center (cancer registry data), and the National Health Insurance Service (morbidity data). Additionally, new participants have been enrolled since 2022 as part of an ongoing expansion. This population-based cohort, enriched with genetic data, provides a robust foundation for research aimed at elucidating causal relationships in chronic disease.
- 29 July 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025040
Open AccessCohort profile update: the Korean Cancer Prevention Study-II (KCPS-II) biobank
Chronic diseases such as cancer and cardiovascular disease have a substantial impact on mortality and global disease burden. The Korean Cancer Prevention Study-II (KCPS-II) biobank was established to investigate these chronic diseases, with a particular focus on metabolic risk factors. Recently, genetic information reflecting diverse ancestries has been incorporated to support a precision medicine approach. These data can be leveraged to identify variation in causal effects among different ancestral groups, thereby informing the development of more effective, ancestry-specific treatments. From 2004 to 2013, baseline data were collected from 156,701 individuals aged 20-85 years, recruited from 18 health promotion centers across Korea. Outcome data are routinely obtained from Statistics Korea (mortality data), the National Cancer Center (cancer registry data), and the National Health Insurance Service (morbidity data). Additionally, new participants have been enrolled since 2022 as part of an ongoing expansion. This population-based cohort, enriched with genetic data, provides a robust foundation for research aimed at elucidating causal relationships in chronic disease.
- Open Access
- 14 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-10
Cohort profile: the Korean National Health Examination Baseline (KNHEB) cohort for longitudinal health monitoring in South Korea
Background: The Korean National Health Examination Baseline (KNHEB) cohort was established in 2019 by the Korea Disease Control and Prevention Agency and the National Health Insurance Service to address research gaps and improve standardized monitoring of the health effects of smoking and other modifiable risk factors. It provides scientific evidence to inform national policies on tobacco control and other health determinants, aiming to reduce preventable mortality and disease burden in South Korea. Methods: The cohort includes 8,916,544 individuals aged ≥ 20 who underwent general health screenings in 2002–2003. It integrates three linked databases: insurance eligibility, medical visits (diagnostic codes, healthcare utilization), and health check-ups (behavioral risk factors, blood test results, etc.). Medical visit and health check-up data were collected until December 2018, while mortality records have been updated through 2019 and continue to be updated annually. At baseline, the mean age of participants was 44.2 years (SD 13.8). The mean follow-up duration was 16.2 years (SD 2.6) for health check-ups among all participants and 9.7 years (SD 4.6) for mortality among deceased individuals. The cohort enables long-term analysis of health outcomes, including cause-specific mortality based on death records and disease incidence identified through diagnostic codes and medical visit data. Findings to date: Analyses using the KNHEB cohort have provided key insights into smoking-related health risks. One study estimated that 60,213 smoking-attributable deaths occurred in South Korea in 2020, while another identified smoking intensity as the strongest predictor of all-cause mortality. Ongoing research include examining the effect of combined health-related factors (HRFs) on cause-specific mortality across age groups and investigating long-term smoking trajectories and alcohol consumption patterns in relation to major non-communicable diseases (NCDs). Conclusions: The KNHEB cohort provides a large-scale, population-based dataset that supports comprehensive analyses of the long-term effects of modifiable risk factors on NCDs. Its findings contribute to evidence-based policymaking in South Korea and offer comparative insights for global research on chronic disease prevention and risk factor management. Furthermore, its standardized data collection and integration with health records facilitate cross-country comparisons, reinforcing its value as a model for large-scale epidemiological studies on NCDs.
- 14 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-10
Open AccessCohort profile: the Korean National Health Examination Baseline (KNHEB) cohort for longitudinal health monitoring in South Korea
Background: The Korean National Health Examination Baseline (KNHEB) cohort was established in 2019 by the Korea Disease Control and Prevention Agency and the National Health Insurance Service to address research gaps and improve standardized monitoring of the health effects of smoking and other modifiable risk factors. It provides scientific evidence to inform national policies on tobacco control and other health determinants, aiming to reduce preventable mortality and disease burden in South Korea. Methods: The cohort includes 8,916,544 individuals aged ≥ 20 who underwent general health screenings in 2002–2003. It integrates three linked databases: insurance eligibility, medical visits (diagnostic codes, healthcare utilization), and health check-ups (behavioral risk factors, blood test results, etc.). Medical visit and health check-up data were collected until December 2018, while mortality records have been updated through 2019 and continue to be updated annually. At baseline, the mean age of participants was 44.2 years (SD 13.8). The mean follow-up duration was 16.2 years (SD 2.6) for health check-ups among all participants and 9.7 years (SD 4.6) for mortality among deceased individuals. The cohort enables long-term analysis of health outcomes, including cause-specific mortality based on death records and disease incidence identified through diagnostic codes and medical visit data. Findings to date: Analyses using the KNHEB cohort have provided key insights into smoking-related health risks. One study estimated that 60,213 smoking-attributable deaths occurred in South Korea in 2020, while another identified smoking intensity as the strongest predictor of all-cause mortality. Ongoing research include examining the effect of combined health-related factors (HRFs) on cause-specific mortality across age groups and investigating long-term smoking trajectories and alcohol consumption patterns in relation to major non-communicable diseases (NCDs). Conclusions: The KNHEB cohort provides a large-scale, population-based dataset that supports comprehensive analyses of the long-term effects of modifiable risk factors on NCDs. Its findings contribute to evidence-based policymaking in South Korea and offer comparative insights for global research on chronic disease prevention and risk factor management. Furthermore, its standardized data collection and integration with health records facilitate cross-country comparisons, reinforcing its value as a model for large-scale epidemiological studies on NCDs.
- Open Access
- 6 December 2024
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 46, e2024096
Causal effect of fasting serum glucose on atherosclerotic cardiovascular disease: a multivariable Mendelian randomization
OBJECTIVES: Observational studies have reported that diabetes is a risk factor that increases the risk of atherosclerotic cardiovascular disease (ASCVD). However, the causal relationship remains a matter of debate. This study aimed to analyze the relationship between fasting serum glucose (FSG) and ASCVD.METHODS: This study used data from the Korean Cancer Prevention Study-II (KCPS-II) Biobank, consisting of 159,844 people recruited with consent from 18 health examination centers from 2004 to 2013. Outcomes were confirmed based on diagnoses on hospital discharge summaries from National Health Insurance System. We used linear and non-linear Mendelian randomization (MR) methods. The outcome data were obtained from KCPS-II, and the exposure data were derived from the Korean Genome Epidemiology Study.RESULTS: First, a prospective cohort study estimated that for each 10 mg/dL increase in FSG level, the risk of ASCVD increased by 4% (hazard ratio [HR], 1.04; 95% confidence interval [CI], 1.03 to 1.05). Second, the 2-sample MR study showed that every 10 mg/dL increase in FSG influenced the risk of ASCVD (odds ratio [OR], 1.11; 95% CI, 1.04 to 1.18). Third, the multivariable MR study showed that the OR per 10 mg/dL increase in FSG on ASCVD was 1.14 (p<0.001). Similar results were found for a 10 mg/dL increase in FSG and ischemic heart disease (IHD), but a significant relationship with stroke was not found. When performing non-linear MR, a linear relationship was observed between fasting blood sugar and ASCVD, including IHD and stroke.CONCLUSIONS: FSG showed a linear and causal association with IHD, but not with stroke.
- 6 December 2024
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 46, e2024096
Open AccessCausal effect of fasting serum glucose on atherosclerotic cardiovascular disease: a multivariable Mendelian randomization
OBJECTIVES: Observational studies have reported that diabetes is a risk factor that increases the risk of atherosclerotic cardiovascular disease (ASCVD). However, the causal relationship remains a matter of debate. This study aimed to analyze the relationship between fasting serum glucose (FSG) and ASCVD.METHODS: This study used data from the Korean Cancer Prevention Study-II (KCPS-II) Biobank, consisting of 159,844 people recruited with consent from 18 health examination centers from 2004 to 2013. Outcomes were confirmed based on diagnoses on hospital discharge summaries from National Health Insurance System. We used linear and non-linear Mendelian randomization (MR) methods. The outcome data were obtained from KCPS-II, and the exposure data were derived from the Korean Genome Epidemiology Study.RESULTS: First, a prospective cohort study estimated that for each 10 mg/dL increase in FSG level, the risk of ASCVD increased by 4% (hazard ratio [HR], 1.04; 95% confidence interval [CI], 1.03 to 1.05). Second, the 2-sample MR study showed that every 10 mg/dL increase in FSG influenced the risk of ASCVD (odds ratio [OR], 1.11; 95% CI, 1.04 to 1.18). Third, the multivariable MR study showed that the OR per 10 mg/dL increase in FSG on ASCVD was 1.14 (p<0.001). Similar results were found for a 10 mg/dL increase in FSG and ischemic heart disease (IHD), but a significant relationship with stroke was not found. When performing non-linear MR, a linear relationship was observed between fasting blood sugar and ASCVD, including IHD and stroke.CONCLUSIONS: FSG showed a linear and causal association with IHD, but not with stroke.
- Open Access
- 31 July 2024
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 57 (4) , 327-338
Smoking-attributable Mortality in Korea, 2020: A Meta-analysis of 4 Databases
Objectives: Estimating the number of deaths caused by smoking is crucial for developing and evaluating tobacco control and smoking cessation policies. This study aimed to determine smoking-attributable mortality (SAM) in Korea in 2020.Methods: Four large-scale cohorts from Korea were analyzed. A Cox proportional-hazards model was used to determine the hazard ratios (HRs) of smoking-related death. By conducting a meta-analysis of these HRs, the pooled HRs of smoking-related death for 41 diseases were estimated. Population-attributable fractions (PAFs) were calculated based on the smoking prevalence for 1995 in conjunction with the pooled HRs. Subsequently, SAM was derived using the PAF and the number of deaths recorded for each disease in 2020.Results: The pooled HR for all-cause mortality attributable to smoking was 1.73 for current men smokers (95% confidence interval [CI], 1.53 to 1.95) and 1.63 for current women smokers (95% CI, 1.37 to 1.94). Smoking accounted for 33.2% of all-cause deaths in men and 4.6% in women. Additionally, it was a factor in 71.8% of men lung cancer deaths and 11.9% of women lung cancer deaths. In 2020, smoking was responsible for 53 930 men deaths and 6283 women deaths, totaling 60 213 deaths.Conclusions: Cigarette smoking was responsible for a significant number of deaths in Korea in 2020. Monitoring the impact and societal burden of smoking is essential for effective tobacco control and harm prevention policies.
- 31 July 2024
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 57 (4) , 327-338
Open AccessSmoking-attributable Mortality in Korea, 2020: A Meta-analysis of 4 Databases
Objectives: Estimating the number of deaths caused by smoking is crucial for developing and evaluating tobacco control and smoking cessation policies. This study aimed to determine smoking-attributable mortality (SAM) in Korea in 2020.Methods: Four large-scale cohorts from Korea were analyzed. A Cox proportional-hazards model was used to determine the hazard ratios (HRs) of smoking-related death. By conducting a meta-analysis of these HRs, the pooled HRs of smoking-related death for 41 diseases were estimated. Population-attributable fractions (PAFs) were calculated based on the smoking prevalence for 1995 in conjunction with the pooled HRs. Subsequently, SAM was derived using the PAF and the number of deaths recorded for each disease in 2020.Results: The pooled HR for all-cause mortality attributable to smoking was 1.73 for current men smokers (95% confidence interval [CI], 1.53 to 1.95) and 1.63 for current women smokers (95% CI, 1.37 to 1.94). Smoking accounted for 33.2% of all-cause deaths in men and 4.6% in women. Additionally, it was a factor in 71.8% of men lung cancer deaths and 11.9% of women lung cancer deaths. In 2020, smoking was responsible for 53 930 men deaths and 6283 women deaths, totaling 60 213 deaths.Conclusions: Cigarette smoking was responsible for a significant number of deaths in Korea in 2020. Monitoring the impact and societal burden of smoking is essential for effective tobacco control and harm prevention policies.
- Open Access
- 19 December 2023
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 46, e2024011
Smoking-attributable mortality among Korean adults in 2019
OBJECTIVES: Tobacco use ranks among the leading preventable causes of death worldwide. This study was conducted to calculate the mortality rate attributable to smoking in Korea for 2019 and to highlight the importance of tracking and monitoring smoking-related deaths for public health purposes.METHODS: Population attributable risk (PAR) was used to estimate the number of deaths related to smoking in 2019. PAR percentages were applied to the estimated mortality figures for various diseases, with PAR determined based on relative risk (RR). Levin’s formula was used to calculate PAR, and RR was adjusted for age and alcohol consumption using Cox proportional hazards regression model to derive disease-specific regression coefficients. The analysis incorporated previously determined smoking rates from 1985, and use rates of novel tobacco products were not considered.RESULTS: The findings revealed a total of 67,982 smoking-attributable deaths in Korea in 2019, 56,993 of which occurred in men and 11,049 in women. The PAR of smoking for various causes of death in adult men was highest for lung cancer at 74.9%, followed by pneumonia (29.4%), ischemic heart disease (42.3%), and stroke (30.2%). For women, the PAR for smoking-related death was highest for lung cancer (19.9%), followed by stroke (7.6%), pneumonia (5.7%), and ischemic heart disease (9.1%).CONCLUSIONS: In countries experiencing rapid fluctuations in smoking rates, including Korea, regular studies on smoking-related mortality is imperative. Furthermore, it is necessary to investigate smoking-related deaths, including the prevalence of novel tobacco product use, to accurately gauge the risks associated with emerging tobacco products.
- 19 December 2023
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 46, e2024011
Open AccessSmoking-attributable mortality among Korean adults in 2019
OBJECTIVES: Tobacco use ranks among the leading preventable causes of death worldwide. This study was conducted to calculate the mortality rate attributable to smoking in Korea for 2019 and to highlight the importance of tracking and monitoring smoking-related deaths for public health purposes.METHODS: Population attributable risk (PAR) was used to estimate the number of deaths related to smoking in 2019. PAR percentages were applied to the estimated mortality figures for various diseases, with PAR determined based on relative risk (RR). Levin’s formula was used to calculate PAR, and RR was adjusted for age and alcohol consumption using Cox proportional hazards regression model to derive disease-specific regression coefficients. The analysis incorporated previously determined smoking rates from 1985, and use rates of novel tobacco products were not considered.RESULTS: The findings revealed a total of 67,982 smoking-attributable deaths in Korea in 2019, 56,993 of which occurred in men and 11,049 in women. The PAR of smoking for various causes of death in adult men was highest for lung cancer at 74.9%, followed by pneumonia (29.4%), ischemic heart disease (42.3%), and stroke (30.2%). For women, the PAR for smoking-related death was highest for lung cancer (19.9%), followed by stroke (7.6%), pneumonia (5.7%), and ischemic heart disease (9.1%).CONCLUSIONS: In countries experiencing rapid fluctuations in smoking rates, including Korea, regular studies on smoking-related mortality is imperative. Furthermore, it is necessary to investigate smoking-related deaths, including the prevalence of novel tobacco product use, to accurately gauge the risks associated with emerging tobacco products.
- 17 September 2023
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2023 (1)
A Study on the Association between Body Mass Index and Diabetes Incidence according to the Gamma-Glutamyl Transferase Level in Korea
- 17 September 2023
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2023 (1)
A Study on the Association between Body Mass Index and Diabetes Incidence according to the Gamma-Glutamyl Transferase Level in Korea
- Open Access
- 20 June 2023
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Practice
- Vol. 13 (2) , 88-95
Study on the Criteria for Priority-Setting and Application in Expanding Health Insurance Benefit of Preventive Medical Service: The Case of Obesity
Gyuwon Ra, Sunmi Lee*. Korean J Fam Pract 2023;13:88-95. https://doi.org/10.21215/kjfp.2023.13.2.88
- 20 June 2023
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Practice
- Vol. 13 (2) , 88-95
Open AccessStudy on the Criteria for Priority-Setting and Application in Expanding Health Insurance Benefit of Preventive Medical Service: The Case of Obesity
Gyuwon Ra, Sunmi Lee*. Korean J Fam Pract 2023;13:88-95. https://doi.org/10.21215/kjfp.2023.13.2.88
- Open Access
- 13 September 2022
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 44, e2022075
Prediction of cancer survivors’ mortality risk in Korea: a 25-year nationwide prospective cohort study
OBJECTIVES: This study aimed to investigate the factors affecting cancer survival and develop a mortality prediction model for Korean cancer survivors. Our study identified lifestyle and mortality risk factors and attempted to determine whether health-promoting lifestyles affect mortality.METHODS: Among the 1,637,287 participants in the Korean Cancer Prevention Study (KCPS) cohort, 200,834 cancer survivors who were alive after cancer diagnosis were analyzed. Discrimination and calibration for predicting the 10-year mortality risk were evaluated. A prediction model was derived using the Cox model coefficients, mean risk factor values, and mean mortality from the cancer survivors in the KCPS cohort.RESULTS: During the 21.6-year follow-up, the all-cause mortality rates of cancer survivors were 57.2% and 39.4% in men and women, respectively. Men, older age, current smoking, and a history of diabetes were high-risk factors for mortality, while exercise habits and a family history of cancer were associated with reduced risk. The prediction model discrimination in the validation dataset for both KCPS all-cause mortality and KCPS cancer mortality was shown by C-statistics of 0.69 and 0.68, respectively. Based on the constructed prediction models, when we modified exercise status and smoking status, as modifiable factors, the cancer survivors’ risk of mortality decreased linearly.CONCLUSIONS: A mortality prediction model for cancer survivors was developed that may be helpful in supporting a healthy life. Lifestyle modifications in cancer survivors may affect their risk of mortality in the future.
- 13 September 2022
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 44, e2022075
Open AccessPrediction of cancer survivors’ mortality risk in Korea: a 25-year nationwide prospective cohort study
OBJECTIVES: This study aimed to investigate the factors affecting cancer survival and develop a mortality prediction model for Korean cancer survivors. Our study identified lifestyle and mortality risk factors and attempted to determine whether health-promoting lifestyles affect mortality.METHODS: Among the 1,637,287 participants in the Korean Cancer Prevention Study (KCPS) cohort, 200,834 cancer survivors who were alive after cancer diagnosis were analyzed. Discrimination and calibration for predicting the 10-year mortality risk were evaluated. A prediction model was derived using the Cox model coefficients, mean risk factor values, and mean mortality from the cancer survivors in the KCPS cohort.RESULTS: During the 21.6-year follow-up, the all-cause mortality rates of cancer survivors were 57.2% and 39.4% in men and women, respectively. Men, older age, current smoking, and a history of diabetes were high-risk factors for mortality, while exercise habits and a family history of cancer were associated with reduced risk. The prediction model discrimination in the validation dataset for both KCPS all-cause mortality and KCPS cancer mortality was shown by C-statistics of 0.69 and 0.68, respectively. Based on the constructed prediction models, when we modified exercise status and smoking status, as modifiable factors, the cancer survivors’ risk of mortality decreased linearly.CONCLUSIONS: A mortality prediction model for cancer survivors was developed that may be helpful in supporting a healthy life. Lifestyle modifications in cancer survivors may affect their risk of mortality in the future.
- Open Access
- 1 January 2020
- Published by XMLink in Korean Circulation Journal
- Vol. 50 (10) , 940-948
Two-Sample Mendelian Randomization Study of Lipid levels and Ischemic Heart Disease
Korean Circulation Journal 대한심장학회지 순환기 Lee SH, et al. Korean Circ J. 2020 Oct;50(10):940-948. https://doi.org/10.4070/kcj.2020.0131
- 1 January 2020
- Published by XMLink in Korean Circulation Journal
- Vol. 50 (10) , 940-948
Open AccessTwo-Sample Mendelian Randomization Study of Lipid levels and Ischemic Heart Disease
Korean Circulation Journal 대한심장학회지 순환기 Lee SH, et al. Korean Circ J. 2020 Oct;50(10):940-948. https://doi.org/10.4070/kcj.2020.0131